295 related articles for article (PubMed ID: 37007005)
1. Nanoconstructs for theranostic application in cancer: Challenges and strategies to enhance the delivery.
Mishra S; Bhatt T; Kumar H; Jain R; Shilpi S; Jain V
Front Pharmacol; 2023; 14():1101320. PubMed ID: 37007005
[TBL] [Abstract][Full Text] [Related]
2. Triptorelin Tethered Multifunctional PAMAM-Histidine-PEG Nanoconstructs Enable Specific Targeting and Efficient Gene Silencing in LHRH Overexpressing Cancer Cells.
Tambe P; Kumar P; Karpe YA; Paknikar KM; Gajbhiye V
ACS Appl Mater Interfaces; 2017 Oct; 9(41):35562-35573. PubMed ID: 28949503
[TBL] [Abstract][Full Text] [Related]
3. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
Bar-Zeev M; Livney YD; Assaraf YG
Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
[TBL] [Abstract][Full Text] [Related]
4. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
Hou L; Shan X; Hao L; Feng Q; Zhang Z
Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
[TBL] [Abstract][Full Text] [Related]
5. Critical parameters for design and development of multivalent nanoconstructs: recent trends.
Bakshi AK; Haider T; Tiwari R; Soni V
Drug Deliv Transl Res; 2022 Oct; 12(10):2335-2358. PubMed ID: 35013982
[TBL] [Abstract][Full Text] [Related]
6. Deformable Discoidal Polymeric Nanoconstructs for the Precise Delivery of Therapeutic and Imaging Agents.
Palange AL; Palomba R; Rizzuti IF; Ferreira M; Decuzzi P
Mol Ther; 2017 Jul; 25(7):1514-1521. PubMed ID: 28341562
[TBL] [Abstract][Full Text] [Related]
7. Thrombus-specific theranostic nanocomposite for codelivery of thrombolytic drug, algae-derived anticoagulant and NIR fluorescent contrast agent.
Chang LH; Chuang EY; Cheng TM; Lin C; Shih CM; Wu AT; Jheng PR; Lu HY; Shih CC; Mi FL
Acta Biomater; 2021 Oct; 134():686-701. PubMed ID: 34358695
[TBL] [Abstract][Full Text] [Related]
8. Theranostic Liposome-Nanoparticle Hybrids for Drug Delivery and Bioimaging.
Seleci M; Ag Seleci D; Scheper T; Stahl F
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28671589
[TBL] [Abstract][Full Text] [Related]
9. Immune Cell-Mediated Biodegradable Theranostic Nanoparticles for Melanoma Targeting and Drug Delivery.
Xie Z; Su Y; Kim GB; Selvi E; Ma C; Aragon-Sanabria V; Hsieh JT; Dong C; Yang J
Small; 2017 Mar; 13(10):. PubMed ID: 28026115
[TBL] [Abstract][Full Text] [Related]
10. Gene expression, biodistribution, and pharmacoscintigraphic evaluation of chondroitin sulfate-PEI nanoconstructs mediated tumor gene therapy.
Pathak A; Kumar P; Chuttani K; Jain S; Mishra AK; Vyas SP; Gupta KC
ACS Nano; 2009 Jun; 3(6):1493-505. PubMed ID: 19449835
[TBL] [Abstract][Full Text] [Related]
11. Tumor Penetrating Theranostic Nanoparticles for Enhancement of Targeted and Image-guided Drug Delivery into Peritoneal Tumors following Intraperitoneal Delivery.
Gao N; Bozeman EN; Qian W; Wang L; Chen H; Lipowska M; Staley CA; Wang YA; Mao H; Yang L
Theranostics; 2017; 7(6):1689-1704. PubMed ID: 28529645
[TBL] [Abstract][Full Text] [Related]
12. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
13. Functionalization of Platinum Complexes for Biomedical Applications.
Wang X; Wang X; Guo Z
Acc Chem Res; 2015 Sep; 48(9):2622-31. PubMed ID: 26247558
[TBL] [Abstract][Full Text] [Related]
14. Treating colon cancers with a non-conventional yet strategic approach: An overview of various nanoparticulate systems.
Bhaskaran NA; Kumar L
J Control Release; 2021 Aug; 336():16-39. PubMed ID: 34118336
[TBL] [Abstract][Full Text] [Related]
15. Engineered Hybrid Nanoparticles for On-Demand Diagnostics and Therapeutics.
Nguyen KT; Zhao Y
Acc Chem Res; 2015 Dec; 48(12):3016-25. PubMed ID: 26605438
[TBL] [Abstract][Full Text] [Related]
16. Camptothecin-loaded fusogenic nanodroplets as ultrasound theranostic agent in stem cell-mediated drug-delivery system.
Ho YJ; Chiang YJ; Kang ST; Fan CH; Yeh CK
J Control Release; 2018 May; 278():100-109. PubMed ID: 29630986
[TBL] [Abstract][Full Text] [Related]
17. Smart and Multi-Functional Magnetic Nanoparticles for Cancer Treatment Applications: Clinical Challenges and Future Prospects.
Aram E; Moeni M; Abedizadeh R; Sabour D; Sadeghi-Abandansari H; Gardy J; Hassanpour A
Nanomaterials (Basel); 2022 Oct; 12(20):. PubMed ID: 36296756
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances in Metal-Organic Frameworks as Anticancer Drug Delivery Systems: A Review.
Karami A; Mohamed O; Ahmed A; Husseini GA; Sabouni R
Anticancer Agents Med Chem; 2021; 21(18):2487-2504. PubMed ID: 33463479
[TBL] [Abstract][Full Text] [Related]
19. RNA Aptamer-functionalized Polymeric Nanoparticles in Targeted Delivery and Cancer Therapy: An up-to-date Review.
Marangoni K; Menezes R
Curr Pharm Des; 2022; 28(34):2785-2794. PubMed ID: 36056830
[TBL] [Abstract][Full Text] [Related]
20. Precision Atomistic Structures of Actinium-/Radium-/Barium-Doped Lanthanide Nanoconstructs for Radiotherapeutic Applications.
Goswami M; Toro-González M; Moon J; Davern S
ACS Nano; 2024 Jul; 18(26):16577-16588. PubMed ID: 38885179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
